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Conclusions: 1) ICP use is steadily increasing in MI pts ineligible for TTX
in Israel; 2) increased ICP rates are associated with decrease of early death

























In the reperfusion era thrombolytic trials reported a "smoker's paradox" in
which a favorable clinical outcome was noted in smokers. This was thought
to be due in part to the hypercoagulable state with smoking, resulting in a
more thrombotic coronary occlusion which responds well to thrombolysis.
To determine whether the type of reperfusion strategy affects outcome in
smokers vs. nonsmokers, we evaluated 395 patients (pts) who were random-
ized to tPA vs. primary PTCA in the PAMI study of whom 168 were smokers
(SM) and 128 never smoked INS). The combined in-hospital outcome includ-
ing death, recurrent MI or recurrent ischemia was similar in SM and NS (p
= 0.12) despite univariate analysis revealing that SM were younger (65 vs.
55 yrs, p < 0.001) and less likely to be female (20 vs. 41%, P < 0.001) com-
pared with NS. Stratifying the data according to reperfusion modality, smok-
ers treated with tPA did significantly better than NS (p = 0.041; a difference
that did not exist in the PTCA group (SM vs NS, p = 0.69). Multivariate anal-
ysis revealed that NS treated with PTCA had less recurrent ischemia (11 vs.
33%, p ~ 0.004) and combined mortality or recurrent MI (7 vs 18%, P =
0.05) compared with those treated with tPA. At 6 months, NS treated with
PTCA vs. tPA continued to have fewer deaths or recurrent MI. (11 vs. 24%,
P = 0.07). Conversely, treatment strategy in SM did not significantly affect
hospital outcomes; recurrent ischemia (12 vs. 23%, P = 0.07) and mortality
combined with recurrent MI (6 vs. 8%, P = 0.55) in PTCA and tPA groups. The
statistical significance of these associations is maintained when controlling
for age and gender.
Conclusion: Nonsmokers presenting with acute MI have a significantly bet-
ter outcome after treatment with primary angioplasty. Even when controlling
for age and gender the reperfusion strategy affects outcome in NS, a differ-
ence not seen in SM. These data add further support to the hypothesis that
nonsmokers have a more atherosclerotic occlusion which may explain why
they benefit from primary angioplasty more than thrombolysis.
ST elevation MI (n = 94):
Age 2: 75 yrs (n ~ 78):
Onset ~ 12 hrs (n = 1631:
Chronic angina (n = 114):
Chronic CHF In = 51):
Prior MI (n = 108):
Hospital death (n ~ 28):
The most common reason for not treating with n was absence of criteria
for ST elevation MI in 179/222 pts 181 %). Of 35/222 (16%) who presented
between 4-12 hrs, age or duration of symptoms was the sole contraindica-
tion to n in only 8 (4%). Other less common major contra indications to TT
included prolonged chest massage, recent surgery, active internal bleeding,
and hemodynamic instability. Conclusions: 1) Most pts did not receive n.
2) Even with expanded treatment criteria, few additional pts become can-
didates for n. 3) Future research should focus on the majority of the MI
population which fails to meet ECG or other n criteria.
Thrombolytic therapy In) clearly saves lives in acute myocardial infarction
IMI). but the major limitation to its widespread use has been the large propor-
tion of M I pts considered ineligible for n. In recent overviews of the large
randomized n trials, net benefit is consistently seen with: 1) ST elevation
Mlldiagnostic ST elevations in any anatomic location) or left bundle branch
block on presenting ECG; 2) any age; and 3) onset of symptoms < 12 hrs.
To describe correlates of n utilization and to determine the potential impact
of recently expanded n criteria on the number of untreated pts, we studied
292 pts with acute MI who were admitted via the Emergency Department
between June 1991 and December 1992 into a large university teaching hos-
pital.
Results: 222 (76%) did not receive n. Univariate correlates of n utilization:
Eligibility for Thrombolytic Therapy is Limited
Even with Expanded Criteria
Christopher J. O'Donnell, Kim A. Eagle, Patrick T. O'Gara, Sum ita D. Paul.
Massachusetts General Hospital and Harvard Medical School, Boston, MA
The Reperfusion Strategy Does Affect Outcome
When Nonsmokers Present with Acute
Myocardial Infarction: A PAMI Substudy
Terry R. Bowers, Edward F. Terrien, Sylvia Puchrowicz-Ochocki, Debra Sachs,
William W. O'Neill, Cindy L. Grines. William Beaumont Hospital, Royal Oak, MI
In order to determine whether expanding use of thrombolytic therapy (n)
has influenced overall acute myocardial infarction (AMI) outcome, we eva 1-
Expanding Indications for Thrombolytic Therapy
Improves Acute Myocardial Infarction Outcome
George R. McKendall, Steven Reinert, Mary Jane McDonald, David O. Williams.
Rhode Island Hospital, Brown University. Providence, Rhode Island
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Method of Reducing Emergency Room Time to




The Use of Invasive Coronary Procedures Have
Increased and Prognosis Improved in Patients
Ineligible for Thrombolysis in Israel
Solomon Behar, Shmuel Gottlieb, Gavriel Barbash, Thrombolytic Israeli Survey
Group. Neufeld Cardiac Research Institute, Tel-Aviv University. Israel
Characteristics (%) 1990 (n = 267) 1992 In ~ 546) 1992 In ~ 567)
Men 68 75 69
Age (mean + SO) 65±11yrs 65± 12yrs 65± 12yrs
>75 yrs 21 25 22
First MI 66 63 60
ICP(%)
Coronaro-angiography 15 18 27
PTCA <1 6 11
CABG <1 2 5
Mortality (%) 13 10 8
17 days)
We also instituted this AMI team approach in three area small town rural
hospitals to see if this approach would be beneficial in this setting. Similar
reductions in time to treatment were observed.
Conclusion: 1) AMI team approach effectively lowers time to treatment
in large medical center hospitals and in small town rural hospitals; 2) wide-
spread use of this concept could significant lower mortality from ST segment
elevation AMI in the United States.
vs. other) was the only variable predicting mortality. Age was not a predictive
factor using univariate analysis; using multivariate analysis there was a trend
towards increasing mortality with age, which did not reach statistical signif-
icance. We conclude advanced age is not invariably associated with a fatal
outcome in acute infarction patients with cardiogenic shock and encourage
consideration of infarct angioplasty in patients presenting with shock regard-
less of patient age.
Stephen L. Kopecky, Martha J. Siska, Jean A. Jurek, Stephen F. Gudgell, Thomas
D. Meloy, Deborah R. Fischer, Guy S. Reeder. Mayo Clinic, Rochester, MN
In the United States, the average time between a patient's arrival in the emer-
gency room (ER) and the administration of thrombolytic therapy for ST ele-
vation and acute myocardial infarction (AMI) is over one hour. If the time to
treatment (Rx) after arrival in the ER could be reduced by 30 minutes, it has
been estimated that at least 5,000 lives could be saved annually in the United
States. In our institution, the average time to Rx after arrival in the ER for ST
elevation AMI from June 1991 to June 1993 was 71 ± 32 minutes Imedian
64 minutes). We then developed an "AMI team" approach which included
ER physicians, ER nurses, ECG technicians, and pharmacists. The diagnos-
tic approach of the AMI team was based on two pocket cards that contained
information on the following: 1) indicationslcontraindications of thrombolytic
treatment in AMI; 2) thrombolytic treatment drug selection guidelines ItPA
versus SK); 31 ancillary therapy drugs and dosages; and 4) ancillary therapy
indications/contraindications. Treatment by the AMI team centered around
an AMI kit-a tackle box that contained both thrombolytic drugs, all necessary
ancillary treatments (ASA. heparin, beta blockers, nitrates, MS, and magne-
sium) and IVtubing plus drug compatibility charts The time to Rx before and
after institution of the AMI team was as follows:
Patients (pts) with acute myocardial infarction (AMII ineligible for throm-
bolytic therapy (TTX) are at increased risk. Invasive coronary procedures (ICP)
have been recommended for these pts. In 3 surveys performed in the CCU's
of Israel during 1990, '92 and '94 the use of nx was 35, 46 and 43% respec-
tively. The characteristics and management of excluded pts from TTX in the
respective surveys were as follows:
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uated 1205 consecutive AMI patients (pts) with ST segment elevation who
presented from 1989 to 1993. Baseline characteristics of age (64 ± 13 years).
gender (70% male), and n contraindications (38%) did not vary from year to
year. Characteristics of pts treated with n by year are shown.
1989 1990 1991 1992 1993 P
n treated % (n) 42(87) 45(113) 45(104) 63(156) 65(175) 0.0001
Mean age (yrs) 58 ± 11 58 ± 11 57 ± 13 60 ± 11 60 ± 13 0190
Age> 76(%) 23 1.0 1.9 7.7 9.1 0003
Male(%) 75 75 85 73 71 0150
Symptom duration. min 0010
mean ± SD 87 ± 57 106 ± 96 108 ± 104 119 ± 97 135 ± 112
range 12-307 17--£76 15--£57 12-740 16--£09
median 69 80 80 94 103
AMI mortality (%)
IT treated pts 83 7.1 53 7.7 4.6 0350
No IT pts 21.8 16.2 15.2 139 208 0.447
All pts 160 12.0 109 10.0 10.3 0.050
Utilization of n increased significantly by treating more pts > 76 years
and those with longer symptom duration. Trend analysis demonstrates that
mortality in AMI pts treated with n did not change significantly from year to
year. Overall AMI mortality, however, decreased significantly with expanding
use of n. Thus, use of n can be increased by treating more elderly pts and
those with longer symptom duration. Expanding use of n is associated with
reduction in overall AMI mortality.
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Does Reperfusion Induced by Angioplasty
Confer the Same Benefit as Thrombolysis in
Terms of Late Potentials?
Carma Karam, P. Gabriel Steg, Dominique Himbert, Jean-Michel Juliard,
Marie-Claude Aumont. Hopital Bichat, Paris, F
Angioplasty or thrombolysis (T) during acute myocardial infarction (MI) are
two effective methods for achieving reperfusion, but whether reperfusion
induced by angioplasty confers the same protection against the presence of
late potentials on signal-averaged electrocardiography (SAE) as that induced
by T remains debated. We studied retrospectively 102 consecutive Pts with
successful reperfusion (TIMI grade 3 patency in acute phase), obtained by T,
primary angioplasty (P), or rescue angioplasty (R) during the first 6 hours of
MI. T Pts all had angiography at 90 min to prove reperfusion. All had SAE > 6
days later. Late potentials were defined as ,=:2 of the following criteria: QRS
> 120 msec, RMS40 < 20 f1.v, LAS> 38 msec. Results are (mean ± SD):
John F. Murphy, Nilesh L. Jain, Michael G. Kahn, Calixto A. Romero. Washington
University School of Medicine, St. Louis, MO
Clinical trials to determine the efficacy of thrombolytic therapy trials consider
all patients with acute inferior myocardial infarction (IMI) as a single group,
but these patients have heterogeneous clinical characteristics. Stratification
of IMI patients by the amount of myocardium at risk and the time to treat-
ment should clarify the precise indications for thrombolytic therapy.
This study is an independent secondary analysis of the TIMI II patient data
available through the NHLBI. Clinical features were used to identify IMI sub-
groups in the TIMI II trial characterized by increased myocardium at risk.
There were 861 patients with IMI who had one or more of the following mark-
ers for myocardium at risk: anterior ST depression, hypotension defined as a
systolic blood pressure < 100 mmHg, or advanced AV block. There were 455
patients with IMI who did not have any markers of increased myocardium at
risk. The subgroups for each marker and the group without any marker were
then stratified by time to thrombolysis and their outcomes were compared
to historical controls with hypothesis tests and confidence intervals.
Patients with IMI plus anterior ST depression, hypotension, or AV block
who received thrombolysis had a highly statistically significant decre,1se in
mortality (p < 0.001) compared to historical controls. Patients with IMI plus
hypotension or AV block had a significant decrease in mortality only up to
3 hours from onset of symptoms (p < 0.05). In patients with simple 1MI, an
insignificant relative reduction in mortality of 15.4% was seen from a base-
line mortality of 2.5%. Consequently, thrombolytic therapy cannot be justi-
fied for all patients with IMI, but it is clearly indicated for IMI with anterior
ST depression, advanced AV block, and hypotension. The decrease in mor-
tality for patients with hypotension or AV block declines steeply over the
first 3 hours. IMI with anterior or lateral ST elevation, right ventricular infarc-
tion, or new bundle-branch block is hypothesized to have the same benefit
but could not be tested because the data was not available in the TIMI II
database. To demonstrate significance of the relative reduction in mortality
for patients with simple IMI would require 32,220 patients. For the individual
patient with a simple inferior myocardial infarction, the essentially immate-
rial benefit of 15.4% relative reduction in mortality from a baseline mortality
of 2.5% may not outweigh the risk of a hemorrhagic complication of ther-
apy. In conclusion, IMI patients should be considered on an individual basis,
with consideration given to the amount of myocardium at risk and the time
to treatment.
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1956-1191 Inferior Wall Myocardial Infarction and
Thrombolytic Therapy: An Appraisal of Clinical
Heterogeneity and Indications for Treatment
T P R P
number of Pts 35 40 27
Age (years) 59.9 ± 11 605 ± 14 53 ± 13 <0.04
% males 86 85 93 NS
% anterior 54 58 46 NS
Time to treatment (min) 169 ± 72 212 ± 79 171 ± 76 NS
Time to reperfusion (min) 285 ± 75' 261 ± 90 280 ± 98 NS
Ejection fraction 0 (%) 53 ± 8 45 ± 15 46 ± 14 NS
% Late potentials 43 10 11 <0.001
* time to 90 min angiography with proven reperfusion
o radionuclide left ventricular ejection fraction at discharge
Thus, after MI, the prevalence of late potentials appears lower when acute
reperfusion is obtained by angioplasty rather than by thrombolysis. This dif-
ference does not appear related to differences in time to treatment, time to
reperfusion, left ventricular function or other patient characteristics.
Coronary Artery Bypass without
Cardiopulmonary Bypass for Patients with Acute
Myocardial Infarction
Yaron Moshkovitz, Hanoch Hod 1, Gabriel Amir, Rephael Mohr. Dept. Cardiac
Surgery, Sheba Medical Cente" Israel; 1 Heart Institute, Sheba Medical Cente" Israel
Acute myocardial infarction (AMI) is usually associated with increased mor-
tality and morbidity following standard CABG. Between Jan 1992 and Jul
1994, 47 pts with coronary anatomy suitable for CABG without cardiopul-
monary bypass (CPB) underwent this procedure within one week of AMI.
There were 36(77%) males and 11 (23%)females. Mean agewas 59.6 ± 11.4
years (range 37-80). Thirty-three pts (70%) underwent anterior and 14 (30%)
inferior AMI. Twenty-seven underwent emergency CABG within 48 hours of
AMI, 9 (33%) as a bailout procedure following complicated PTCA. Of this
group, 9 133%) were in cardiogenic shock, and 12 (44%) pts required preop
IABP Twenty pts underwent urgent CABG 2 to 7 days following AMI. one
(5%) with cardiogenic shock, and 3 (15%1 with preop IABP. Mean number
of grafts/pt was 1.8 (range 1-4). and IMA was used in 37 (79%). Only 6 pts
(13%) received a graft to a circumflex marginal branch. There was no opera-
tive mortality, and mean hospital stay was 6.3 ± 2.9 days. At mean follow-up
of 18 ± 8 months, there was one cardiac-related (in a pt with preoperative EF
13%). and 2 non-cardiae-related deaths. Two-year actuarial survival was 92%.
However, in 9 pts (19%) angina returned. Eight had CHF, 5 of whom were in
preoperative cardiogenic shock. These results suggest that CABG without
CPB is a relatively low-risk procedure for AMI pts with coronary anatomy suit-
able for this technique. However, the cost might be increased risk of early
retu rn of angi na.
Effect of Direct Angioplasty on Coronary Flow
Reserve in Acute Myocardial Infarction
Hiroshi Yamaguchi, Yoshihiko Atsuchi, Shinichi Arima, Shouichirou Nakao,
Hiromitsu Tanaka. Kagoshima University, Kagoshima. Japan
To determine the effects of direct angioplasty on coronary flow reserve (CFR)
in reperfused myocardium in patients with acute myocardial infarction lAMI),
we studied 16 patients (ten men and six women, 50 ± 10 (mean ± 1SD)
years old) with anterior AMI undergoing successful direct angioplasty and
